Marín-Ocampo L, Veloza LA, Abonia R, Sepúlveda-Arias JC. Anti-inflammatory activity of triazine derivatives: A systematic review.
Eur J Med Chem 2018;
162:435-447. [PMID:
30469039 DOI:
10.1016/j.ejmech.2018.11.027]
[Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2018] [Revised: 11/08/2018] [Accepted: 11/09/2018] [Indexed: 02/06/2023]
Abstract
Triazines are heterocyclic compounds with a variety of biological activities that have been increasingly studied in recent years due to their versatile structure (three isoforms) and the different derivatives that can be synthesized from them to ensure functional motifs. This systematic review provides the evidence in the literature of the in vitro and in vivo anti-inflammatory activity of triazine derivatives from 2008 to June 2018. Four bibliographical databases were consulted (PubMed, Web of Science, EMBASE and Scopus), and a total of 48 studies were included in this paper based on our eligibility criteria. Although 35.17% of evaluated triazines were demonstrated to be promising anti-inflammatory agents, further studies need to be conducted to explore their pharmacological profiles in the medical research of drug discovery to control the risk factors and pathophysiology of several chronic inflammation-based diseases.
Collapse